Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serological screening for herpes simplex virus during pregnancy

D Drago, P Catapano, S Marinangeli

    Clinical and Experimental Obstetrics & Gynecology
    |January 1, 1993
    PubMed
    Summary

    A study of 620 pregnant women in Padua found a high prevalence of Herpes simplex virus (HSV) antibodies at 82.26%. This highlights the importance of understanding HSV in obstetric care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

    British journal of cancer·2023
    Same author

    Chronobiology of acute pancreatitis in a single Italian centre.

    European review for medical and pharmacological sciences·2020
    Same author

    Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.

    Gynecologic oncology·2019
    Same author

    Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.

    Breast cancer research and treatment·2018
    Same author

    Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017

    Area of Science:

    • Virology
    • Obstetrics and Gynecology
    • Public Health

    Background:

    • Herpes simplex virus (HSV) is a common viral infection with significant public health implications.
    • Understanding the prevalence of HSV antibodies in pregnant populations is crucial for managing potential risks during pregnancy and childbirth.

    Purpose of the Study:

    • To determine the seroprevalence of Herpes simplex virus antibodies among pregnant women in the Province of Padua.
    • To assess the implications of HSV antibody prevalence in the context of obstetric care and maternal-fetal health.

    Main Methods:

    • Serological screening was conducted on a cohort of 620 pregnant women residing in the Province of Padua.
    • Antibody activity against Herpes simplex virus was quantified using established serological techniques.

    Related Experiment Videos

    Main Results:

    • A high seroprevalence rate of 82.26% for Herpes simplex virus antibodies was identified in the studied pregnant population.
    • The findings indicate widespread prior exposure to HSV within this demographic.

    Conclusions:

    • The high prevalence of HSV antibodies in pregnant women underscores the need for awareness and appropriate management strategies in obstetric settings.
    • Further research may be warranted to explore the clinical significance and potential transmission risks associated with this prevalence.